Celltrion: “Zymfentra prescriptions surging in the U.S.… growth is accelerating in earnest”
Celltrion’s subcutaneous formulation for autoimmune diseases, “Zymfentra,” which launched in the United States, has seen prescriptions rise sharply...
Search results for "drugs"
"It Wasn't Just Weight Loss That Improved My Knees"...Ozempic Study Confirms Cartilage 'Metabolic Changes'
"Please lose some weight." This is a common phrase heard when visiting a hospital for knee pain. As weight increases, the burden on the knee joints...
Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?
Huwons Global's subsidiary Huwons Lab is challenging the formulation change platform business that converts intravenous...
The Eye Supplement Myth: Is Lutein and Vitamin A Really Necessary for Your Vision?
"In the past, many people lost their vision because we lacked specialized treatments for ophthalmic diseases.
Korean Biotech Firms Join Forces to Uncover the Hidden Profiles of Cancer Cells
Even within a single tumor, cancer cells present many different "faces." While they may appear as a uniform mass, every...
Scentless Tea and Ineffective Medicine: The Hidden Conditions of "Essence"
“I thought there was a separate species of jasmine tea tree!” This is a common reaction when people learn that jasmine...
Decoding the Blueprint of Aging: Scientists Map 7 Million Cells Across 21 Organs
We often attribute the appearance of wrinkles, declining stamina, and increased disease risk simply to "getting older.
When Life Mimics Art: Why a Cancer Diagnosis Can Trigger a ‘Breaking Bad’ Effect
In the critically acclaimed series Breaking Bad, a mild-mannered chemistry teacher responds to a terminal cancer...
Beyond the X-Ray: South Korean Researchers Develop AI to Pinpoint Precise Knee Osteoarthritis Wear
A South Korean research team has developed a breakthrough imaging indicator that utilizes AI deep learning to identify...
Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum
Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty...